Oculis (OCS) announced the vesting and settlement of Restricted Stock Units (RSUs) for two company directors - Anthony Rosenberg and Arshad Khanani. The transactions occurred in May 2025 as part of previously granted RSU compensation packages. This type of transaction is a routine part of executive compensation where RSUs convert to actual shares based on a predetermined vesting schedule.
Loading...
Loading translation...
Positive
None.
Negative
None.
News Market Reaction – OCS
-1.49%
1 alert
-1.49%News Effect
On the day this news was published, OCS declined 1.49%, reflecting a mild negative market reaction.
ZUG, Switzerland, June 03, 2025 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting and settlement of RSUs previously granted to directors of the Company.
What type of transaction did Oculis (OCS) announce on June 3, 2025?
Oculis announced the vesting and settlement of Restricted Stock Units (RSUs) for two company directors, Anthony Rosenberg and Arshad Khanani.
Who were the directors involved in the Oculis RSU vesting announcement?
The RSU vesting involved two Oculis directors: Anthony Rosenberg and Arshad Khanani.
When did the RSU vesting for Oculis directors take place?
The RSU vesting took place in May 2025.
What are RSUs in the context of the Oculis announcement?
RSUs (Restricted Stock Units) are a form of executive compensation that convert to actual company shares according to a predetermined vesting schedule.